
About Metrasens
Metrasens is an Industrial Goods & Manufacturing company based in Malvern (United Kingdom) founded in 2005 by Matt Wooliscroft, Mark Keene, and Simon Goodyear. Advanced detection technologies are provided for secure environments. Metrasens has raised $12.99 million across 7 funding rounds. Metrasens was last valued at $12.8 million in November 2020. Its chief executive, as recorded, is Simon Goodyear. Metrasens offers products and services including Metrasens Ultra, Ferroguard Assure, and Ferroguard Screener. Its focus areas include High Tech, Security & Surveillance Technology, Threat Detection and Ferromagnetic Detection System. Its legal entity is METRASENS LIMITED.
Company details
Founded in 2005, Metrasens is based in Malvern, United Kingdom. Detection technologies are supplied for risk screening in sectors including healthcare, corrections, education, and corporate sites. Solutions are engineered for adaptability across spaces, with emphasis on precision to identify threats while preserving user safety and dignity. Products are tailored to integrate seamlessly into operations, supporting balanced security protocols in diverse facilities.
- Headquarters Malvern, United Kingdom
- Founders Matt Wooliscroft, Mark Keene, Simon Goodyear
- Stage Minicorn
- SectorsIndustrial Goods & Manufacturing
- Website metrasens.com
- Social LinkedIn X Facebook Instagram YouTube
- Legal Name Metrasens Limited
- Date of Incorporation 29 Jun, 2005
- Jurisdiction MALVERN, WORCESTERSHIRE, ENGLAND
- Total Equity Funding$12.99M (USD)
in 7 rounds
- Latest Funding Round$566K (USD), Series A
Nov 2020
Products & Services of Metrasens
Metrasens offers a comprehensive portfolio of products and services, including Metrasens Ultra, Ferroguard Assure, and Ferroguard Screener.
Efficient screening for ferrous threats in diverse environments
Accurate detection for security and risk prevention
Tool for identifying risks in secure settings
Apps and channels of Metrasens
its YouTube channel Metrasens has 717 subscribers and 30 videos.
Videos from Metrasens
The most watched videos on Metrasens's YouTube channel, Metrasens (717 subscribers). Click a video to play it here.
More on Metrasens.
Funding Insights of Metrasens
Metrasens has successfully raised a total of $12.99M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $566 thousand completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $12.99M
- Total Rounds 7
- Last Round Series A — $566,000
- First Round $447,700
(Mar 2007)
All 7 funding rounds of Metrasens with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov 2020 | $566,000 | Series A | $12.8M | – | – |
| Mar 2014 | $2.7M | Series A | $21M | – | – |
| Mar 2013 | $4.5M | Series A | $••••• | – | – |
| Oct 2011 | $1.2M | Seed | $••••• | – | – |
| Feb 2010 | $3.3M | Seed | $••••• | – | – |
| Sep 2009 | $277,600 | Seed | $••••• | – | – |
| Mar 2007 | $447,700 | Seed | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Nov 2020 | $12.8M | •••••••• |
| Mar 2014 | $21M | •••••••• |
| Mar 2013 | $••••• | •••••••• |
| Oct 2011 | $••••• | •••••••• |
| Feb 2010 | $••••• | •••••••• |
| Sep 2009 | $••••• | •••••••• |
Full valuation and stage history of Metrasens
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $12.8M (Nov 2020).
People of Metrasens
28 people are tracked at Metrasens (15 in leadership, 13 in team).
| Name | Role | Group |
|---|---|---|
Matt Wooliscroft | Co-Founder & Chief Engineer | Leadership |
Mark Keene | Co-Founder & CSO | Leadership |
Simon Goodyear | Co-Founder & CEO & President | Leadership |
Tim Lyons | Chief Financial Officer | Leadership |
Dan Kuzniewski | VP, Marketing | Leadership |
Samer K. | Head Of Engineering | Leadership |
Mariam Zare | Director Of Business Development | Leadership |
Brandon Taylor | Senior Director Of MRI Safety, US & Canada | Leadership |
Kelly Woods | Senior Director Of Commercial Operations | Leadership |
Ximena Velasquez Lino | Director Of Product Marketing | Leadership |
Chris Arbeitman | Vice President Of Market And Business Development | Leadership |
Elsie Ng | Director Of Business Development Asia Pacific Region | Leadership |
Ben Biss | Director Of Business Development - UK | Leadership |
Douglas Miorandi | Global Director, Strategic Business Development: Fortune 500, Tech Sector, Us/allied Governments | Leadership |
David Link | Director Of Sales, US Corrections | Leadership |
Patrick Clark | Business Development Manager | Team |
Mrso Kellye Mantooth Rt Mrse (R MR MRSC MRSC) | Manager, MRI Safety Training & Education | Team |
Sian Winterton | Electronic Engineer | Team |
Ben Mellors | Instrumentation Physics Team Lead | Team |
Jemma Needham | Signal Processing Team Leader | Team |
8 more people are available in the full profile.
Complete people profiles for Metrasens
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Metrasens
4 dated milestones of Metrasens across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Metrasens is founded.
- Funding First funding round of $448K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Series A, of $566K.
Web traffic of Metrasens
The website of Metrasens (metrasens.com) receives about 3.9K visits a month.
- Monthly visits3.9K
▲ 17.1% vs previous month
Websites whose visitors overlap most with Metrasens. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| citilog.com | 100% | View details | |||
| scanna-msc.com | 100% | #3,894,430 | View details | ||
innervision.co.jp | innervision.co.jp | 58% | #480,991 | – | |
intoo.co.jp | intoo.co.jp | 37% | #11,717,290 | – | |
magresource.com | magresource.com | 32% | #11,813,466 | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Metrasens
Complete news archive for Metrasens
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metrasens
Metrasens was founded in 2005 and raised its 1st funding round 2 years after it was founded.
Metrasens is headquartered in Malvern, United Kingdom. It is registered at Malvern, England, United Kingdom.
Simon Goodyear is the CEO of Metrasens, as recorded in our data. They have also founded this company.
Metrasens is a funded company, having raised a total of $12.99M across 7 funding rounds to date. The company's 1st funding round was a Seed of $447.7K, raised on Mar 2007.
Founded in 2005, Metrasens is based in Malvern, United Kingdom. Detection technologies are supplied for risk screening in sectors including healthcare, corrections, education, and corporate sites. Solutions are engineered for adaptability across spaces, with emphasis on precision to identify threats while preserving user safety and dignity. Products are tailored to integrate seamlessly into operations, supporting balanced security protocols in diverse facilities.
Metrasens offers Metrasens Ultra, Ferroguard Assure, and Ferroguard Screener.
The valuation of Metrasens is $12.8M as of Nov 2020.
Metrasens operates through Metrasens Limited.
